The Point of Care (PoC) Diagnostics Market Report by Reports and Data provides an extensive overview of the vital elements of the Point of Care (PoC) Diagnostics market and factors such as drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others.
New York City, United States – June 27, 2020 /MarketersMedia/ —
According to the current analysis of Reports and Data, the global Point of Care (PoC) Diagnostics market was valued at USD 23.98 Billion in 2018 and is expected to reach USD 50.51 Billion by year 2026, at a CAGR of 9.6%. According to the Centers for Disease Control and Prevention (CDC), in US alone currently more than 100 million adults are living with diabetes or pre-diabetes. Cardiovascular diseases (CVD) account for approximately 800,000 deaths in the US. On average, one person dies from CVD every 40 seconds in the US. CVD also causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union.
This is the latest report covering the current COVID-19 scenario. The coronavirus pandemic has greatly affected every aspect of the worldwide industry. It has brought along various changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact are covered in the research report. The report discusses all the major aspects of the market with expert opinions on the current status along with historical data.
Get a sample PDF copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507
Key players mentioned in the research report are:
Abbott, AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN and Quidel.
In terms of applications, the global Point of Care (PoC) Diagnostics market can be segmented into:
Professional Diagnostic Centres
Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings)
Hospitals/Critical Care Centres
Other End Users
In terms of types, the global Point of Care (PoC) Diagnostics market can be segmented into:
Glucose Monitoring Products
Cardiometabolic Testing Products
Coagulation Testing Products
PT/INR Testing Products
Activated Clotting Time (ACT/APTT) Testing Products
Pregnancy and Fertility Testing Products
Pregnancy Testing Products
To get a discount on the report, click @ https://www.reportsanddata.com/discount-enquiry-form/1507
For geographical segmentation, regional supply, application-wise, and type-wise demand, key players, and others, this report covers the following regions: North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The report sheds light on the competitive landscape of the market that covers the product offerings, services, market shares, and business overview. This Point of Care (PoC) Diagnostics Market research report covers various dynamic aspects like the market drivers, restraints and challenges, and growth prospects. The prominent and leading companies are profiled in the report.
Further key findings from the report suggest:
• Point of Care (PoC) Diagnostics market is fastest growing at a CAGR of 3% in Asia Pacific due to rising prevalence of strategic initiatives taken by international players to improve healthcare infrastructure and increasing awareness in developing countries like China and India
• The market for Molecular diagnostics segment is projected to have the highest CAGR during the forecasted period because of the growing advancements in technology, increasing initiatives of market players for developing POC molecular diagnostics products, and resource-limited settings
• Europe is the second largest region with a share of 33.1 % due to the increased adoption of advanced point of care diagnostic devices, rise in awareness about innovative and advanced applications of point of care diagnostic devices, and rapidly aging population coupled with increase in incidences of diabetes and liver diseases
• Cardiometabolic Testing Products is accounted to be the second leading segment which is valued at USD 5411.7 million due to increasing number of patients with cardiac disorders and a huge demand and supply of cardiometabolic products across the regions
Get the full report description, TOC, Table of Figures, Charts @ https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Release ID: 88965968